# Peginesatide for Maintenance Treatment of Anemia in Participants on Hemodialysis

> **NCT00434330** · PHASE2 · COMPLETED · sponsor: **Affymax** · enrollment: 91 (actual)

## Conditions studied

- Anemia
- Chronic Kidney Disease
- Chronic Renal Failure

## Interventions

- **DRUG:** peginesatide
- **DRUG:** peginesatide
- **DRUG:** peginesatide
- **DRUG:** peginesatide
- **DRUG:** peginesatide
- **DRUG:** peginesatide

## Key facts

- **NCT ID:** NCT00434330
- **Lead sponsor:** Affymax
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2012-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00434330

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00434330, "Peginesatide for Maintenance Treatment of Anemia in Participants on Hemodialysis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00434330. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*